Evidence map›Paper›PMID 40144823›Full record

ArticleJHLT open2025

Severe primary graft failure: Are there lasting impacts? Analysis from the PHTS Database.

Jennifer Conway, Tara Pidborochynski, James K Kirklin, Ryan Cantor, Hong Zhao, Aryaz Sheybani, Jacqueline Lamour, Lakshmi Gokanapudy Hahn, Leslie Collins, Jessica Laks and 1 more

Abstract read
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jennifer ConwayStollery Children's Hospital, Edmonton, Alberta, Canada.
Tara PidborochynskiDepartment of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
James K KirklinKirklin Solutions, Hoover, Alabama.
Ryan CantorKirklin Solutions, Hoover, Alabama.
Hong ZhaoKirklin Solutions, Hoover, Alabama.
Aryaz SheybaniNemours Children's Hospital, Wilmington, Delaware.
Jacqueline LamourMount Sinai Medical Center, New York, New York.
Lakshmi Gokanapudy HahnWashington University in St. Louis, St. Louis, Missouri.
Leslie CollinsUniversity of Alabama at Birmingham, Birmingham, Alabama.
Jessica LaksJohns Hopkins All Children's Hospital, St. Petersburg, Florida.
Darren H FreedDepartment of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Primary graft failure (PGF) is a leading cause of early morbidity and mortality after heart transplantation (HTx). PGF is secondary to graft ischemia and ischemia-reperfusion injuries to the cardiomyocytes and vasculature of the donor heart after transplantation. Longer-term outcomes after PGF are not well studied. Methods: Patients with an HTx (January 1, 2010 to June 30, 2022) were identified using the Pediatric Heart Transplant Society registry. PGF was defined as death, retransplantation, or need for mechanical circulatory support within 72 hours of HTx. Kaplan-Meier analysis and Cox proportional hazard modeling were utilized. Results: Of the 4,982 patients with a primary HTx, 5.4% ( Conclusions: Severe PGF is an independent predictor of early mortality post-HTx but subsequently does not further impact long-term survival, overall risk of rejection, or CAV. Understanding the impact of milder forms of PGF on survival and long-term outcomes is still needed. Methods to decrease the risk of PGF, such as alternative preservation and storage techniques, may impact early mortality post-HTx.

Indexed as

allograft vasculopathypediatricsprimary graft failurerejectionsurvival

Identifiers

PMID40144823
PMCPMC11935355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.